SCHEMBL670190

SCHEMBL670190

CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCCCCCCN(C)CCCCCCCCCCCCCCCCCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.62
TSHR P16473 1/20 0.62
DNM1 Q05193 3/20 0.50
EPHX1 P07099 2/20 0.50
ADH1B P00325 1/20 0.50
ADH1C P00326 1/20 0.50
ADH1A P07327 1/20 0.50
ADH4 P08319 1/20 0.50
ADH7 P40394 1/20 0.50
S1PR2 O95136 6/20 0.48
S1PR1 P21453 6/20 0.48
S1PR3 Q99500 6/20 0.48
S1PR5 Q9H228 2/20 0.48
S1PR4 O95977 5/20 0.45
KDM5A P29375 2/20 0.44
KDM4C Q9H3R0 2/20 0.44
PHF8 Q9UPP1 1/20 0.44
CHRM2 P08172 1/20 0.42
KDM5C P41229 1/20 0.42
KDM5B Q9UGL1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18173957 1.00 ALDH1A1 (0.62) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL25914078 1.00 ALDH1A1 (0.62) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL31325292 1.00 ALDH1A1 (0.62) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL21498012 0.98 ALDH1A1 (0.59) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL26144828 0.95 ALDH1A1 (0.62) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL17266680 0.90 CHRM2 (0.61) ALDH1A1TSHRDNM1EPHX1CHRM2
SCHEMBL20091201 0.89 ALDH1A1 (0.54) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL20091177 0.89 ALDH1A1 (0.54) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL20091178 0.89 ALDH1A1 (0.54) ALDH1A1TSHRDNM1EPHX1ADH1B
SCHEMBL20091166 0.89 ALDH1A1 (0.54) ALDH1A1TSHRDNM1EPHX1ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9358186-B2 Foamed personal care composition obtainable by aerating and heating a base composition CONOPCO, INC. (US) 2016-06-07 US disclosed
US-20140350224-A1 FOAMED PERSONAL CARE COMPOSITION OBTAINABLE BY AERATING AND HEATING A BASE COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2014-11-27 US disclosed
EP-2770976-A2 FOAMED PERSONAL CARE COMPOSITION OBTAINABLE BY AERATING AND HEATING A BASE COMPOSITION Unilever Plc. (GB) 2014-09-03 EP disclosed
EP-2605742-A1 HAIR TREATMENT COMPOSITION Unilever PLC (GB) 2013-06-26 EP disclosed
WO-2013060590-A2 COMPOSITION UNILEVER PLC (GB) 2013-05-02 WO disclosed
WO-2013057066-A2 TREATMENT COMPOSITION UNILEVER PLC (GB) 2013-04-25 WO disclosed
WO-2012059440-A2 TREATMENT COMPOSITION UNILEVER PLC (GB) 2012-05-10 WO disclosed
WO-2012022749-A1 HAIR TREATMENT COMPOSITION UNILEVER PLC (GB) 2012-02-23 WO disclosed
US-5726137-A WATER INSOLUBLE LIPID PHASE CONTAINING MONOCATIONIC CONDITIONING AGENT, IMPROVED COMPATIBILITY BETWEEN ANIONIC AND CATIONIC AGENTS COLGATE-PALMOLIVE COMPANY (US) 1998-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350224-A1 FOAMED PERSONAL CARE COMPOSITION OBTAINABLE BY AERATING AND HEATING A BASE COMPOSITION CUTA, S100A9, HIRA ALDH1A1 2782/4885TSHR 4167/4885DNM1 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.